Article
Effective treatment of different phenotypes of chronic urticaria with omalizumab: Case reports and review of literature.
International journal of immunopathology and pharmacology - 1 Jun 2016
Kasperska-Zajac A, Jarząb J, Żerdzińska A, Bąk K, Grzanka A
Abstract excerpt
Despite the excellent efficacy and safety profile of omalizumab in chronic spontaneous urticaria (CSU), there are scarce data concerning its role in the treatment of refractory cases with different phenotypes of urticaria. We describe our experience with the therapy of nine patients with CSU co-existing with delayed pressure urticaria (DPU) or angioedema or both and refractory to treatment with high-dose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
